Clinical Trials
3 trialsNCT05445908 2026-05-08
SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2 Active not recruiting
NCT07371208 2026-01-27
ST-A-TN
Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
NCT07109284 2025-08-07
NeoSaciA
West China Hospital
Phase 2 Not yet recruiting